Mary Feldman, MD
NPI 1396767893 · Dermatopathology Physician · Carrollton, GA
Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1396767893
- Entity type
- Individual
- Primary specialty
- Dermatopathology PhysicianAllopathic & Osteopathic Physicians
- Credential
- MD
- Sex
- Female
- Sole proprietor
- Yes
- License
- 2003004218 (MO)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Allopathic & Osteopathic Physicians
Allopathic & Osteopathic Physicians
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure28% of score
19 yrs in NPPES registry
- Profile completeness28% of score
100% of core fields populated
- Practice footprint17% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)28% of score
4,154 Medicare services, 2024 (ranked within specialty)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Destruction of Precancer Skin Growth, 2-14 Growths17003 | 1,207 | $6 |
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 707 | $84 |
| Biopsy of Related Skin Growth, First Growth11102 | 421 | $80 |
| Destruction of Precancer Skin Growth, 1 Growth17000 | 410 | $44 |
| Biopsy of Related Skin Growth, Each Additional Growth11103 | 271 | $45 |
| Destruction of Skin Growth, 1-14 Growths |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 21 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Ketoconazole | 223 | 99 |
| Triamcinolone Acetonide | 214 | 136 |
| Cephalexin | 183 | 139 |
| Doxycycline Monohydrate | 161 | 108 |
| Hydrocortisone | 122 | 80 |
| Mupirocin | 90 | 77 |
| Betamethasone Dipropionate | 77 | 45 |
| Mirtazapine | 55 |
Practice location
Mailing address
Registry dates
- Enumerated
- 2006-07-24
- Last updated
- 2017-04-19
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.